Oliva

Oliva Competitive Intelligence & Landscape

oliva.health ·

Overview

Oliva Overview

Oliva is a company with diverse operations across different sectors, including healthcare and tobacco. In the tobacco industry, Oliva Cigar Co. is a well-known manufacturer of premium cigars primarily produced in Nicaragua and sold internationally. The company has a rich history dating back to 1886, originating from Cuba, and was established as Oliva Cigar Co. in 1995 in Miami Lakes, Florida, by the Oliva family, who emigrated from Cuba and Nicaragua (Wikipedia). Its core products are various cigar brands, catering to cigar enthusiasts worldwide (Wikipedia).

In addition to tobacco, Oliva operates in the healthcare sector, particularly in Eurasian Union markets and Georgia, where it provides complex healthcare infrastructure solutions, including digital health platforms, AI-driven diagnostics, and medical technology integration. This division emphasizes reliability, innovation, and compliance with global standards, collaborating with government and private healthcare institutions (oliva-inc.com). Furthermore, Oliva has a presence in mental health and team performance enhancement through its platform Oli, which offers coaching, therapy, and performance improvement tools for teams and individuals (betterwitholi.com, oliva.health).

Overall, Oliva's mission appears to focus on delivering high-quality, innovative products and services across its diverse sectors, emphasizing reliability, health, and performance enhancement, with a strong foundation rooted in its history of tobacco craftsmanship and modern healthcare solutions.

Oliva

Oliva Weekly Intel Updates

Receive weekly intel updates about Oliva straight to your inbox.

Competitors

Oliva Competitors

Oliva faces competition from several prominent AI and sales productivity platforms in 2026, each with unique differentiators and market positioning. One of its top competitors is Oliv AI, which emphasizes its ability to unify deal data from over 30 tools, automate tasks, and provide real-time insights to sales teams. Oliv AI's strength lies in its comprehensive data integration and AI-driven automation, with plans starting at $19 per month, making it an attractive option for sales teams seeking efficiency gains (aichief.com).

Oliv AI is positioned as a revenue intelligence platform that enhances sales productivity through AI agents like Deal Driver and CRM Manager, focusing on deal tracking, risk flagging, and pipeline management. Compared to Oliva, Oliv AI offers more specialized AI agents and a broader focus on revenue orchestration, with a competitive edge in automation and data-driven insights (aichief.com).

Another key competitor is Oliv, known for its conversational intelligence and sales automation features. It integrates deal data from multiple sources, delivers insights directly to users, and automates routine tasks, similar to Oliv AI but with a stronger emphasis on conversational AI and sales engagement. Pricing details are competitive, and its market share is growing among revenue teams seeking comprehensive AI-driven sales solutions (oliv.ai).

Oliv also competes with platforms like Salesforce Einstein and Gong, which are established in the sales intelligence and conversation analytics space. These platforms are distinguished by their extensive ecosystems and integrations, but often come at higher price points. Oliv’s more targeted approach and lower entry cost make it a compelling alternative for mid-sized businesses aiming for AI-enhanced sales productivity (saasworthy.com).

In summary, Oliva’s main competitors differentiate themselves through data integration capabilities, AI automation, and pricing strategies, with Oliv AI and Oliv leading in automation and revenue insights, and larger platforms like Salesforce and Gong offering broader ecosystems for enterprise clients.

Product & Pricing

Oliva Product and Pricing Intelligence

Oliva Product and Pricing Intelligence offers a variety of plans tailored to different organizational needs, with transparent and flexible pricing models. The platform provides a free 14-day trial for teams, with no-cost migration from other tools, and viewers and collaborators are always free. The paid plans include a Personal option at $19 per user per month, which offers unlimited meeting transcription, automated video recording, and AI summary notes, among other features (Oliv AI Pricing). For teams, additional AI insights packs such as Meeting Insights and Deal Insights are available at $29 per user per month, with the total yearly cost for a team of 10 estimated at $2,280 (Oliv AI Pricing).

Recent updates indicate that Oliva continues to expand its AI-driven features, including AI agents that handle specific tasks like deal tracking and CRM management, which enhance productivity and data unification across multiple tools (Gong Blog). The platform emphasizes ease of use, with plans based on annual commitments and payments, and offers scalable options for larger teams, including those with 250+ members. Overall, Oliva’s pricing structure is designed to be transparent, competitive, and adaptable to various organizational sizes and needs (Oliv AI Pricing).

Ad Campaigns

Oliva Ad Campaigns

Oliva is currently running 64 ads across LinkedIn — 64 on LinkedIn. Explore Oliva's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.

See of Oliva's ads

View ads

Hiring & Layoffs

Oliva Hiring and Layoffs

Recent information indicates that Oliva has been actively expanding and evolving its business operations. As of early 2026, the company secured €5 million in funding to enhance its workplace mental health support services, reflecting a strategic focus on employee well-being and organizational growth (employernews.co.uk). This funding follows a period of significant growth, with the company doubling its team size and increasing its network of therapists from 50 to over 250 within the past year, highlighting a strong emphasis on mental health and employee support (employernews.co.uk).

In terms of hiring trends, Oliva has been actively recruiting, with job openings listed as recently as September 2025, primarily in the Philippines, across various categories such as accounting, finance, administration, and IT, indicating ongoing expansion and diversification of roles (kalibrr.com). The company’s hiring patterns suggest a strategic move towards scaling operations and enhancing its service offerings, especially in mental health support, which aligns with its recent funding and growth initiatives. There have been no publicly reported layoffs, which signals a stable growth trajectory rather than restructuring. Overall, Oliva’s hiring and expansion strategies reflect a company committed to scaling its impact in mental health services while investing in employee well-being and organizational development (Welcome to the Jungle).

Leadership

Oliva Management and Leadership Team

The leadership team of Oliva Management is led by Cory Bappert, who serves as the Chief Executive Officer, and Gilberto Oliva, the President of the company (theorg.com). As of September 2023, Gilberto Oliva is recognized as the President, overseeing the company's strategic direction and growth (theorg.com).

Recent leadership changes include the appointment of Dhaval Doshi as Chief Operating Officer at Oliva Skin & Hair Clinic in February 2026, indicating ongoing leadership updates at different Oliva entities (medianews4u.com). However, specific recent changes or additions to the leadership team at the Oliva Cigar Company beyond September 2023 are not detailed in the available sources.

The company's executive structure appears stable with key figures such as Cory Bappert and Gilberto Oliva maintaining leadership roles, and there are no reports of significant recent board member changes or notable hires at the C-suite level within the latest available data (theorg.com).

Financials

Oliva Financial Performance, Fundraising, M&A

Oliva Resource Capital has demonstrated exceptional financial performance in 2025, delivering a remarkable 151% return on its assets, which significantly outperformed typical benchmarks in the commodity sector (Crux Investor). The company's share price also surged by 240% during the same period, reflecting strong investor confidence and effective portfolio management (Crux Investor). While specific revenue figures are not disclosed, the asset growth and share price appreciation indicate robust financial health and successful strategic positioning in commodities like gold and copper, which saw record gains in 2025 (Olive Resource Capital).

Regarding fundraising, there is no detailed information available in the provided sources about recent funding rounds or valuations. However, the company is publicly listed on the TSXV under the ticker OC, which suggests it has access to public capital markets for funding and liquidity (Olive Resource Capital).

In terms of M&A activity, Olive Resource Capital is positioning itself ahead of a potential M&A wave in 2026, supported by its strong performance and record free cash flow generation. The company anticipates increased merger and acquisition activity driven by high commodity prices and record cash flows at major producers, which could lead to strategic acquisitions or partnerships in the near future (Crux Investor).

Partnerships

Oliva Partnerships, Clients and Vendors

Oliva Partnerships encompass collaborations with leading healthcare and technology firms, with a notable example being its long-term partnership with Rio Biopharmaceuticals, which focuses on product commercialization and distribution rights in North America (BioSpace). The company also maintains strategic alliances within the healthcare infrastructure sector across Eurasian Union countries and Georgia, working closely with government healthcare institutions and private medical sectors to implement complex digital and clinical solutions (Oliva Inc.).

In terms of key enterprise clients, Oliva has engaged with major healthcare providers and government projects, delivering integrated healthcare infrastructure solutions, including AI-powered data processing systems and digital platforms for clinical innovation (Oliva Projects & Services). Their ecosystem includes partnerships with global technology providers such as Fujifilm and other industry leaders, facilitating the integration of advanced medical and diagnostic technologies (Oliva About Us).

Oliva’s vendor relationships are characterized by collaborations with specialized companies like Zyromski Horticulture and Pépinière Villeneuve, which supply horticultural products, and with digital solution developers like nventive, which design custom mobile and web applications to support their digital health initiatives (Oliva Capital Portfolio). These ecosystem relationships enable Oliva to offer comprehensive solutions spanning healthcare, agriculture, and technology sectors, reinforcing its position as a multidisciplinary innovator in emerging markets.

Events

Oliva Event Participations

Oliva Event Participations are primarily centered around their involvement in the hospitality and event staffing industry, with a focus on mobile bar production and event staffing services in Central and South Florida. They are known for hosting and attending various community events, although specific conferences, trade shows, webinars, or sponsorship activities are not explicitly detailed in the available search results (Oliva Bar Events).

While there is no direct mention of Oliva participating in major industry conferences or trade shows, their active engagement in local events suggests a focus on community involvement and event hosting within their regional market. Additionally, the search results highlight other professionals and organizations involved in diverse fields such as healthcare, technology, and research, but these are not directly linked to Oliva's event participation activities (Elizabeth Oliva, Lauren Oliva, Gustavo A. Oliva).

In summary, based on the current search results, Oliva's event participation appears to be primarily local and operational rather than through prominent industry conferences, trade shows, or webinars. For more detailed or specific information, direct inquiries to Oliva or their official website may be necessary (Oliva Bar Events).

Frequently Asked Questions

What does Oliva's €5M funding round and rapid therapist network expansion signal about its near-term growth strategy?

Oliva is prioritizing supply-side scale before demand saturates — growing its therapist network from 50 to over 250 within a single year while doubling its internal headcount. The €5M raise secured in early 2026 appears earmarked for accelerating that infrastructure build-out in workplace mental health, suggesting the company is racing to establish network density before better-funded competitors entrench in the same B2B channel.

What does Oliva's hiring pattern across accounting, finance, admin, and IT roles in the Philippines suggest about its operational model?

Oliva is building a distributed, cost-efficient back-office operation, with job openings in the Philippines as recently as September 2025 spanning accounting, finance, administration, and IT. This points to a deliberate strategy of offshoring operational overhead while concentrating higher-cost headcount in core therapy and product functions — a typical move for a Series A-stage health-tech company trying to extend runway post-raise.

Is the absence of reported layoffs at Oliva a genuine signal of stability, or does it reflect a company still too early-stage to restructure?

No publicly reported layoffs, combined with team doubling and active hiring across multiple functions, suggests genuine growth-mode stability rather than a restructuring pause. For a company that has just closed a €5M round and is expanding its therapist network aggressively, the absence of cuts is consistent with an organization scaling into new capacity rather than rationalizing existing cost bases.

How does Oliva's therapist-network growth rate compare to what its pricing model can realistically support?

Oliva's personal-tier pricing starts at $19 per user per month, with team-level AI insight packs at $29 per user per month — relatively modest ARR per seat. Scaling a therapist network fivefold (50 to 250+) in one year creates significant supply-side cost before enterprise contract density catches up, which likely explains the €5M raise. Unless Oliva is closing large employer contracts at volume, margin compression in the near term is a structural risk worth tracking.

What does Oliva's B2B employer channel focus tell us about how it is differentiating from direct-to-consumer mental health platforms?

Oliva is explicitly positioned as a workplace mental health solution sold through employers, not individuals — evidenced by its team performance coaching tools, employer-facing marketing, and the framing of its €5M raise around 'workplace mental health support.' This puts it in direct competition with EAP (Employee Assistance Program) providers and platforms like Unmind or Spill rather than consumer apps like Headspace. The B2B channel offers higher contract values and lower churn, but requires longer sales cycles and HR-budget approval.

What does the appointment of Dhaval Doshi as COO at Oliva Skin & Hair Clinic in February 2026 reveal about Oliva's entity structure?

The Doshi appointment at Oliva Skin & Hair Clinic is a separate operating entity from Oliva's workplace mental health platform (oliva.health), highlighting that 'Oliva' is not a single company but a fragmented namespace across healthcare, tobacco, and mental health verticals. For competitive intelligence purposes, analysts should distinguish Oliva (oliva.health) — the mental health and coaching platform — from the skin clinic, cigar, and resource capital entities that share the brand name.

What does Oliva's partnership with global technology providers like Fujifilm signal about the ambition of its healthcare infrastructure division?

Oliva's healthcare infrastructure arm (oliva-inc.com), operating in Eurasian Union markets and Georgia, has aligned with enterprise-grade partners like Fujifilm, indicating an intent to deliver complex, capital-intensive diagnostic and digital health deployments rather than lightweight SaaS. This division targets government and private hospital systems, which implies long contract cycles, high implementation costs, and dependency on government procurement timelines — a very different risk profile than the consumer-facing mental health platform.

How exposed is Oliva's competitive position in the AI sales-intelligence space given the presence of Salesforce Einstein and Gong?

Oliva's sales-intelligence product competes at the lower end of the market, with entry pricing around $19–$29 per user per month against Gong and Salesforce Einstein, which command significantly higher ASPs and benefit from deep CRM ecosystem lock-in. Oliva's differentiation appears to rest on affordability and targeted AI agents for deal tracking and CRM automation, but its market share remains limited; it is positioned as a mid-market alternative rather than an enterprise incumbent, leaving it vulnerable to commoditization as larger platforms push down-market.

What is the strategic logic behind Oliva offering a free 14-day trial with no-cost migration, and what does it reveal about their customer acquisition bottleneck?

The combination of a free trial and zero-cost migration from competing tools signals that Oliva's primary acquisition barrier is switching cost, not price awareness. Removing migration friction is a deliberate tactic to accelerate trials for teams already on a competing platform, suggesting Oliva's sales data shows that prospects who experience the product convert but that inertia — not skepticism — is the main obstacle. It is a common PLG (product-led growth) tactic at Oliva's funding stage.

What does Oliva's multi-sector brand fragmentation — cigars, mental health, healthcare infrastructure, bar events — mean for any corp-dev team evaluating an acquisition or partnership?

The 'Oliva' namespace is occupied by legally distinct entities across premium cigars (Oliva Cigar Co., founded 1995), workplace mental health SaaS (oliva.health), healthcare infrastructure in Eurasia (oliva-inc.com), and event staffing (Oliva Bar Events). A corp-dev team must conduct rigorous entity-level diligence to avoid conflating financials, leadership, or IP across these unrelated businesses. The mental health platform (oliva.health) is the entity with the €5M 2026 funding signal and the therapist-network growth story.

Does Oliva's €5M raise constitute a meaningful war chest relative to the cost of scaling a therapist marketplace, or is another round likely near-term?

€5M is a modest raise for a company that has already doubled headcount and grown its clinical network fivefold. Running a two-sided marketplace of 250+ therapists with associated compliance, supervision, and quality-assurance overhead is capital-intensive, and the funding likely provides 12–18 months of runway at current burn assuming controlled hiring pace. A follow-on Series A or strategic raise within 18 months of the early 2026 close would be consistent with this trajectory, and ForesightIQ tracks funding signals across the digital mental health sector to flag these windows.

What does Oliva's limited presence at major industry conferences suggest about its current go-to-market maturity?

There is no evidence of Oliva (oliva.health) participating in major digital health or HR-tech conferences or trade shows; its event footprint appears localized and community-oriented. For a B2B workplace mental health platform, conference visibility at events like HLTH, HR Tech, or Employee Benefits Live would be a standard demand-generation lever. Its absence could indicate early-stage GTM with budget prioritized toward product and clinical supply rather than brand, or it may signal that its primary sales motion is inbound and partnership-led rather than field-marketing-driven.

Powered by ForesightIQ · Competitive intelligence from digital exhaust